From April 1, 2023 to June 30, 2023, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 37,238 shares, representing 0.31% for KRW 2,914.01 million under the buyback announced on October 13, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
102,600 KRW | -0.97% | -1.63% | -21.62% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.62% | 967M | |
+18.67% | 43.74B | |
+23.79% | 22.26B | |
+16.41% | 14.9B | |
+9.03% | 13.39B | |
+40.48% | 12.12B | |
-8.88% | 6.92B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.47B |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.